MetaModix Funding & Investors

MetaModix manufactures surgical and medical instruments for the treatment of metabolic diseases and Type II diabetes. The company's first product, the EndoSleeve, is designed to be a safer and more cost-effective treatment option for patients suffering from type 2 diabetes, NASH, and obesity. It was founded in 2009 and is headquartered in Plymouth, Minnesota, United States.

Total Amount Raised: $5,710,169

MetaModix Funding Rounds

Series Unknown
$500,000
Jan 25, 2023
Series Unknown
$500,000
Jan 25, 2023
Series Unknown
$100,000
Jul 11, 2018
Series Unknown
$1,200,000
Mar 28, 2017
Series Unknown
$100,000
Dec 22, 2016
Series Unknown
$141,985
May 7, 2016
Series A
$1,750,000
Jun 23, 2015
Series A Investors
Antipodean Advisors
Series Unknown
$29,434
Jan 12, 2015
Series Unknown
$150,000
Apr 7, 2014
Series Unknown
$450,000
Mar 27, 2013
Seed
$993,750
Jun 4, 2012
Seed
$295,000
Aug 5, 2010
Series Unknown
$100,000
Jul 11, 2018
Series Unknown
$1,200,000
Mar 28, 2017
Series Unknown
$100,000
Dec 22, 2016
Series Unknown
$141,985
May 7, 2016
Series A
$1,750,000
Jun 23, 2015
Series A Investors
Antipodean Advisors
Series Unknown
$29,434
Jan 12, 2015
Series Unknown
$150,000
Apr 7, 2014
Series Unknown
$450,000
Mar 27, 2013
Seed
$993,750
Jun 4, 2012
Seed
$295,000
Aug 5, 2010

Funding info provided by Diffbot.